146 related articles for article (PubMed ID: 35056067)
1. Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.
Broqueza J; Prabaharan CB; Allen KJH; Jiao R; Fisher DR; Dickinson R; MacDonald-Dickinson V; Uppalapati M; Dadachova E
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056067
[TBL] [Abstract][Full Text] [Related]
2. Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
Karkare S; Allen KJH; Jiao R; Malo ME; Dawicki W; Helal M; Godson DL; Dickinson R; MacDonald-Dickinson V; Yang R; Hoang B; Gorlick R; Geller DS; Dadachova E
Sci Rep; 2019 Aug; 9(1):11476. PubMed ID: 31391495
[TBL] [Abstract][Full Text] [Related]
3. Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody.
Allen KJH; Kwon O; Hutcheson MR; Grudzinski JJ; Cain SM; Cruz FA; Vinayakamoorthy RM; Sun YS; Fairley L; Prabaharan CB; Dickinson R; MacDonald-Dickinson V; Uppalapati M; Bednarz BP; Dadachova E
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513891
[TBL] [Abstract][Full Text] [Related]
4. Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma.
Giri S; Allen KJH; Prabaharan CB; Ramirez JB; Fiore L; Uppalapati M; Dadachova E
Nucl Med Biol; 2024 May; 134-135():108917. PubMed ID: 38718557
[TBL] [Abstract][Full Text] [Related]
5. Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).
Prabaharan CB; Giri S; Allen KJH; Bato KEM; Mercado TR; Malo ME; Carvalho JLC; Dadachova E; Uppalapati M
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570809
[TBL] [Abstract][Full Text] [Related]
6. Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma.
Broqueza J; Prabaharan CB; Andrahennadi S; Allen KJH; Dickinson R; MacDonald-Dickinson V; Dadachova E; Uppalapati M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34064450
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
Boisclair C; Dickinson R; Giri S; Dadachova E; MacDonald-Dickinson V
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768202
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).
Geller DS; Morris J; Revskaya E; Kahn M; Zhang W; Piperdi S; Park A; Koirala P; Guzik H; Hall C; Hoang B; Yang R; Roth M; Gill J; Gorlick R; Dadachova E
Nucl Med Biol; 2016 Dec; 43(12):812-817. PubMed ID: 27744117
[TBL] [Abstract][Full Text] [Related]
9. Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium.
Allen KJH; Jiao R; Malo ME; Frank C; Fisher DR; Rickles D; Dadachova E
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323785
[TBL] [Abstract][Full Text] [Related]
10. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
11. Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma.
Fu Y; Yu J; Liatsou I; Du Y; Josefsson A; Nedrow JR; Rindt H; Bryan JN; Kraitchman DL; Sgouros G
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4382-4393. PubMed ID: 35809088
[TBL] [Abstract][Full Text] [Related]
12. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
[TBL] [Abstract][Full Text] [Related]
13. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
[TBL] [Abstract][Full Text] [Related]
14. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
[TBL] [Abstract][Full Text] [Related]
15. Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
Kaminski MS; Fig LM; Zasadny KR; Koral KF; DelRosario RB; Francis IR; Hanson CA; Normolle DP; Mudgett E; Liu CP
J Clin Oncol; 1992 Nov; 10(11):1696-711. PubMed ID: 1403053
[TBL] [Abstract][Full Text] [Related]
16. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
17. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
18. Biodistributions of 177Lu- and 111In-labeled 7E11 antibodies to prostate-specific membrane antigen in xenograft model of prostate cancer and potential use of 111In-7E11 as a pre-therapeutic agent for 177Lu-7E11 radioimmunotherapy.
Pan MH; Gao DW; Feng J; He J; Seo Y; Tedesco J; Wolodzko JG; Hasegawa BH; Franc BL
Mol Imaging Biol; 2009; 11(3):159-66. PubMed ID: 19034582
[TBL] [Abstract][Full Text] [Related]
19. Dose predictions for [
Ku A; Kondo M; Cai Z; Meens J; Li MR; Ailles L; Reilly RM
EJNMMI Radiopharm Chem; 2021 Aug; 6(1):25. PubMed ID: 34383182
[TBL] [Abstract][Full Text] [Related]
20. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
